United States

Annexon is a clinical-stage biopharmaceutical company that develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. Its product candidates include monoclonal antibodies and small molecules that target distinct disease processes. The company's lead candidate, ANX005, is in Phase II/III clinical trials for guillain-barré syndrome and other indications. Annexon was founded in 2011 and is headquartered in Brisbane, California.

Google

Menadžer proizvoda

Naučnik podataka

Annexon Biosciences

Annexon Biosciences Otvoreni poslovi

Da li ste spremni da unapredite svoju karijeru? Pogledajte ove otvorene pozicije u Annexon Biosciences.